Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01057615 · ClinicalTrials.gov registry record · Phase 1

Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma

A Phase 1 study, sponsored by Indiana University.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target

NCT01057615: Completed Phase 1 study, sponsored by Indiana University.

NCT01057615 is a Phase 1 study that has completed, run by Indiana University. The registered enrollment target is 14 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01057615, a Phase 1 study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target

Study Summary

Combining fish oil and vitamin C supplementation will provide a greater anti-inflammatory effect against developing exercise-induced bronchoconstriction (EIB) than either nutritional supplement alone.

Interventions

  • DIETARY_SUPPLEMENT Ascorbic Acid
  • DIETARY_SUPPLEMENT Fish Oil
  • DIETARY_SUPPLEMENT Fish Oil Placebo
  • DIETARY_SUPPLEMENT Ascorbic Acid Placebo

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2010-03
Est. Completion 2010-12
Phase Phase 1
Indiana University

890 total trials

What the finished NCT01057615 record still lists

NCT01057615 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 4 interventions - of which Ascorbic Acid is the first listed.

NCT01057615 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01057615 about?

NCT01057615 is a clinical study titled "Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma". Combining fish oil and vitamin C supplementation will provide a greater anti-inflammatory effect against developing exercise-induced bronchoconstriction (EIB) than either nutritional supplement alone.

What is the current status of trial NCT01057615?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2010-03. Estimated completion is 2010-12.

What interventions are being tested in trial NCT01057615?

The interventions under investigation include: Ascorbic Acid (DIETARY_SUPPLEMENT), Fish Oil (DIETARY_SUPPLEMENT), Fish Oil Placebo (DIETARY_SUPPLEMENT), Ascorbic Acid Placebo (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01057615?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01057615's enrollment target sits among peer trials

14 1844th of 2000 higher than 154 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01057615, the US trial registry maintained by the National Library of Medicine. NCT01057615 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.